Genfit S.A.(GNFT)Earnings, Financials & Key Ratios
GNFT•NASDAQ
256.9× P/E·Price updated Apr 24, 2026
AboutGenfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagnosis of nonalcoholic steatohepatitis (NASH) and fibrosis; GNS561, which is in Phase 1b/2 trial to treat patients with cholangiocarcinoma (CCA); and Nitazoxanide, which is in Phase 1 trial to treat acute-on-chronic liver failure. The company has a licensing agreement with Labcorp for the commercialization of NASHnext, a blood-based molecular diagnostic test; and with Genoscience Pharma to develop and commercialize the investigational treatment GNS561 for CCA. Genfit S.A. was incorporated in 1999 and is headquartered in Loos, France.Show more
- Revenue$67M+134.6%
- EBITDA$5M+120.1%
- Net Income$2M+105.2%
- EPS (Diluted)0.03+105.2%
- Gross Margin99.55%+0.8%
- EBITDA Margin7.47%+108.6%
- Operating Margin4.9%+105.3%
- Net Margin2.25%+102.2%
- ROE2.2%+106.2%
GNFT Key Insights
Genfit S.A. (GNFT) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓FCF machine: 21.2% free cash flow margin
- ✓Momentum leader: RS Rating 96 (top 4%)
- ✓High quality earnings: Operating CF exceeds net income
- ✓Strong 5Y sales CAGR of 16.8%
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when GNFT posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
GNFT Price & Volume
Genfit S.A. (GNFT) stock price & volume — 10-year historical chart
Loading chart...
GNFT Growth Metrics
Genfit S.A. (GNFT) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years45.15%
5 Years16.79%
3 Years-5.77%
TTM9.75%
Profit CAGR
10 Years-
5 Years-
3 Years-71.81%
TTM-161.19%
EPS CAGR
10 Years-
5 Years-
3 Years-71%
TTM-212.82%
Return on Capital
10 Years-19.12%
5 Years-9.9%
3 Years-9.26%
Last Year3.1%
GNFT Recent Earnings
Genfit S.A. (GNFT) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 4/12 qtrs (50%)●Beat Revenue 6/12 qtrs (75%)
Q2 2025Latest
May 22, 2025Metric
Actual
Est
EPS
$0.64-148.9%
$0.26
Rev
$11M-62.6%
$30M
Q4 2024
Sep 19, 2024Metric
Actual
Est
EPS
$0.54+62.3%
$0.33
Rev
$66M+28.9%
$51M
Q4 2023
Dec 30, 2023Metric
Actual
Est
EPS
$0.18
—
Rev
$19M
—
Q4 2023
Sep 20, 2023Metric
Actual
Est
EPS
$0.45-41.1%
$0.32
Rev
$16M+5.8%
$15M
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2025Latest | May 22, 2025 | $0.64vs $0.26-148.9% | $11Mvs $30M-62.6% |
| Q4 2024 | Sep 19, 2024 | $0.54vs $0.33+62.3% | $66Mvs $51M+28.9% |
| Q4 2023 | Dec 30, 2023 | $0.18 | $19M |
| Q4 2023 | Sep 20, 2023 | $0.45vs $0.32-41.1% | $16Mvs $15M+5.8% |
Based on last 12 quarters of dataView full earnings history →
GNFT Peer Comparison
Genfit S.A. (GNFT) competitors in Metabolic and Obesity Therapies — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 MDGL | 11.66B | 505.75 | -39.36 | 432.05% | -27.32% | -50.15% | 0.59 | |
 AKRO | 4.5B | 54.65 | -14.57 | -30.58% | 0.05 | |||
 HALO | 8.13B | 68.55 | 26.78 | 37.55% | 23.13% | 126.27% | 43.89 | |
 ELVN | 2.75B | 45.10 | -24.64 | -21.04% | 0.00 | |||
 ALDX | 118.23M | 1.96 | -3.50 | -0% | 0.35 | |||
 CRNX | 3.78B | 35.87 | -7.25 | 6.41% | -27.47% | -43.96% | 0.05 | |
 ARWR | 11.52B | 81.82 | -6706.56 | 232.58% | -48.38% | -55.09% | 0.73 | |
 ALNY | 37.1B | 278.09 | 119.35 | 65.19% | 13.46% | 98.29% | 1.62 |
Compare GNFT vs Peers
Genfit S.A. (GNFT) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
GNFT Income Statement
Genfit S.A. (GNFT) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Sales/Revenue | 284K | 118K | 69K | 30.84M | 765K | 80.07M | 20.2M | 28.57M | 67M | 116.8M |
Revenue Growth % | -46.11% | -58.45% | -41.53% | 44594.2% | -97.52% | 10366.54% | -74.78% | 41.45% | 134.56% | 9.75% |
Cost of Goods Sold | 1.99M | 2.23M | 1.85M | 177K | 202K | 161K | 248K | 341K | 300K | -4.71M |
COGS % of Revenue | 698.94% | 1888.98% | 2686.96% | 0.57% | 26.41% | 0.2% | 1.23% | 1.19% | 0.45% | - |
Gross Profit | -1.7M▲ 0% | -2.11M▼ 24.1% | -1.78M▲ 15.4% | 30.66M▲ 1817.8% | 563K▼ 98.2% | 79.91M▲ 14093.3% | 19.95M▼ 75.0% | 28.22M▲ 41.5% | 66.7M▲ 136.3% | 122.47M▲ 0% |
Gross Margin % | -598.94% | -1788.98% | -2586.96% | 99.43% | 73.59% | 99.8% | 98.77% | 98.81% | 99.55% | 104.85% |
Gross Profit Growth % | -21.15% | -24.1% | 15.44% | 1817.76% | -98.16% | 14093.25% | -75.04% | 41.49% | 136.33% | - |
Operating Expenses | 32.46M | 54.58M | 67.7M | 88.67M | 78.35M | 53.54M | 47.5M | 54.8M | 63.42M | 129.52M |
OpEx % of Revenue | 11428.17% | 46256.78% | 98115.94% | 287.53% | 10242.35% | 66.87% | 235.19% | 191.86% | 94.66% | - |
Selling, General & Admin | 11.65M | 13.41M | 4.5M | 30.97M | 25.49M | 17.69M | 17.4M | 8.04M | 20.13M | 38.63M |
SG&A % of Revenue | 4103.87% | 11361.02% | 6514.49% | 100.43% | 3331.5% | 22.1% | 86.15% | 28.15% | 30.05% | - |
Research & Development | 19.19M | 35.09M | 47.66M | 66.17M | 59.1M | 35.17M | 35.82M | 46.71M | 47.21M | 74.44M |
R&D % of Revenue | 6755.99% | 29741.53% | 69073.91% | 214.57% | 7725.1% | 43.92% | 177.36% | 163.52% | 70.46% | - |
Other Operating Expenses | 1.61M | 6.08M | 6.41M | -8.47M | -6.23M | 682K | -5.72M | 53K | -3.92M | -79K |
Operating Income | -34.16M▲ 0% | -56.7M▼ 66.0% | -69.48M▼ 22.6% | -57.83M▲ 16.8% | -82.9M▼ 43.3% | 31.82M▲ 138.4% | -27.29M▼ 185.8% | -26.58M▲ 2.6% | 3.28M▲ 112.3% | 517K▲ 0% |
Operating Margin % | -12027.46% | -48046.61% | -100701.45% | -187.53% | -10836.21% | 39.74% | -135.13% | -93.05% | 4.9% | 0.44% |
Operating Income Growth % | -93.25% | -65.98% | -22.56% | 16.77% | -43.34% | 138.38% | -185.77% | 2.6% | 112.34% | - |
EBITDA | -33.36M | -55.16M | -68.05M | -52.58M | -79.34M | 34.56M | -25.46M | -24.93M | 5M | 3.89M |
EBITDA Margin % | -11746.13% | -46748.31% | -98621.74% | -170.5% | -10370.98% | 43.16% | -126.06% | -87.26% | 7.47% | 3.33% |
EBITDA Growth % | -92.28% | -65.36% | -23.36% | 22.73% | -50.89% | 143.56% | -173.66% | 2.09% | 120.08% | -80.99% |
D&A (Non-Cash Add-back) | 799K | 1.53M | 1.44M | 5.25M | 3.56M | 2.74M | 1.83M | 1.65M | 1.72M | 3.37M |
EBIT | -34.16M | -56.69M | -69.53M | -54.28M | -76.58M | 32.16M | -27.64M | -23.89M | 6.62M | -4.76M |
Net Interest Income | 193K | -1.94M | -10.79M | -8.83M | -10.35M | -4.68M | -4.27M | -2.94M | -3M | -3.27M |
Interest Income | 316K | 389K | 202K | 2.63M | 1.44M | 274K | 137K | 1.71M | 1.79M | 5.33M |
Interest Expense | 123K | 2.33M | 10.99M | 11.45M | 11.79M | 4.96M | 4.41M | 4.65M | 4.78M | 7.12M |
Other Income/Expense | 526K | -2.45M | -10.39M | -7.89M | -18.75M | 37.66M | 3.45M | -1.93M | -1.43M | -13.3M |
Pretax Income | -33.63M▲ 0% | -58.22M▼ 73.1% | -79.88M▼ 37.2% | -65.72M▲ 17.7% | -101.65M▼ 54.7% | 69.47M▲ 168.3% | -23.84M▼ 134.3% | -28.51M▼ 19.6% | 1.85M▲ 106.5% | -12.78M▲ 0% |
Pretax Margin % | -11841.55% | -49338.14% | -115760.87% | -213.11% | -13287.45% | 86.77% | -118.03% | -99.82% | 2.76% | -10.94% |
Income Tax | 35K | 384K | -354K | -576K | -428K | 2.21M | -116K | 380K | 340K | 1.68M |
Effective Tax Rate % | -0.1% | -0.66% | 0.44% | 0.88% | 0.42% | 3.19% | 0.49% | -1.33% | 18.41% | -13.13% |
Net Income | -33.67M▲ 0% | -58.6M▼ 74.1% | -79.52M▼ 35.7% | -65.14M▲ 18.1% | -101.22M▼ 55.4% | 67.26M▲ 166.4% | -23.72M▼ 135.3% | -28.89M▼ 21.8% | 1.51M▲ 105.2% | -16.49M▲ 0% |
Net Margin % | -11854.58% | -49664.41% | -115247.83% | -211.24% | -13231.5% | 84% | -117.45% | -101.15% | 2.25% | -14.12% |
Net Income Growth % | -96.48% | -74.07% | -35.69% | 18.08% | -55.38% | 166.45% | -135.27% | -21.81% | 105.22% | -161.19% |
Net Income (Continuing) | -33.66M | -55.73M | -79.52M | -65.14M | -101.22M | 67.26M | -23.72M | -28.89M | 1.51M | -14.46M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -1.25▲ 0% | -1.88▼ 50.4% | -2.55▼ 35.6% | -1.76▲ 31.0% | -2.60▼ 47.7% | 1.23▲ 147.3% | -0.48▼ 139.0% | -0.58▼ 20.8% | 0.03▲ 105.2% | -0.33▲ 0% |
EPS Growth % | -81.16% | -50.4% | -35.64% | 30.98% | -47.73% | 147.31% | -139.02% | -20.83% | 105.17% | -212.82% |
EPS (Basic) | -1.28 | -1.88 | -2.55 | -1.76 | -2.60 | 1.50 | -0.48 | -0.58 | 0.03 | - |
Diluted Shares Outstanding | 26.85M | 31.17M | 31.17M | 36.99M | 38.86M | 55.61M | 49.67M | 49.7M | 50.23M | 49.78M |
Basic Shares Outstanding | 26.35M | 31.16M | 31.17M | 36.99M | 38.86M | 44.74M | 49.67M | 49.82M | 50.23M | 49.78M |
Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
GNFT Balance Sheet
Genfit S.A. (GNFT) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Total Current Assets | 162M | 283.57M | 218.12M | 290.75M | 184.72M | 268.1M | 158.46M | 113.11M | 92.77M | 155.43M |
Cash & Short-Term Investments | 152.28M | 273.82M | 207.24M | 276.75M | 171.03M | 258.76M | 140.55M | 77.79M | 81.79M | 107.51M |
Cash Only | 152.28M | 273.82M | 207.24M | 276.75M | 171.03M | 258.76M | 136M | 77.79M | 81.79M | 107.51M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 4.55M | 0 | 0 | 0 |
Accounts Receivable | 8.39M | 417K | 395K | 12.03M | 11.92M | 7.24M | 15.91M | 32.71M | 7.56M | 36.88M |
Days Sales Outstanding | 10.79K | 1.29K | 2.09K | 142.43 | 5.69K | 32.99 | 287.48 | 417.93 | 41.21 | 115.77 |
Inventory | 14K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K | 4K |
Days Inventory Outstanding | 2.57 | 0.66 | 0.79 | 8.25 | 7.23 | 9.07 | 5.89 | 4.28 | 4.87 | -0.31 |
Other Current Assets | 726K | 7.88M | 8.77M | -1K | 0 | 0 | 0 | 0 | 1K | 6.83M |
Total Non-Current Assets | 4.22M | 9.61M | 11.36M | 19.1M | 13.9M | 13.62M | 57.08M | 60.76M | 58.66M | 61.25M |
Property, Plant & Equipment | 3.01M | 6.32M | 7.76M | 16.45M | 11.65M | 9.02M | 8.21M | 7.87M | 7.59M | 7.91M |
Fixed Asset Turnover | 0.09x | 0.02x | 0.01x | 1.87x | 0.07x | 8.88x | 2.46x | 3.63x | 8.82x | 14.86x |
Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets | 667K | 636K | 795K | 920K | 791K | 174K | 43.96M | 48.76M | 48M | 50.35M |
Long-Term Investments | 109K | 267K | 770K | 1.73M | 1.46M | 4.43M | 4.91M | 2.82M | 1.88M | 9.6M |
Other Non-Current Assets | 433K | 1K | 2.03M | -1K | -11.95M | 3K | -55.78M | 1.3M | 1.18M | 1.3M |
Total Assets | 166.21M▲ 0% | 293.18M▲ 76.4% | 229.48M▼ 21.7% | 309.85M▲ 35.0% | 198.61M▼ 35.9% | 281.72M▲ 41.8% | 215.54M▼ 23.5% | 173.87M▼ 19.3% | 151.42M▼ 12.9% | 216.68M▲ 0% |
Asset Turnover | 0.00x | 0.00x | 0.00x | 0.10x | 0.00x | 0.28x | 0.09x | 0.16x | 0.44x | 0.63x |
Asset Growth % | 139.99% | 76.39% | -21.73% | 35.03% | -35.9% | 41.84% | -23.49% | -19.33% | -12.91% | -20.55% |
Total Current Liabilities | 17.56M | 27.11M | 39.25M | 43.49M | 31.07M | 62.84M | 39.37M | 38.48M | 75.16M | 41.58M |
Accounts Payable | 13.34M | 19.05M | 32.65M | 32.75M | 20.34M | 12.3M | 8.61M | 10.45M | 18.39M | 14.01M |
Days Payables Outstanding | 2.45K | 3.12K | 6.43K | 67.54K | 36.75K | 27.89K | 12.68K | 11.18K | 22.37K | -986.46 |
Short-Term Debt | 1.17M | 2.74M | 2.64M | 2.42M | 2.26M | 1.1M | 4.05M | 6.85M | 55.44M | 16.46M |
Deferred Revenue (Current) | 1K | 1K | 1K | 139K | 124K | 14.3M | 14.48M | 11.69M | 0 | 11.69M |
Other Current Liabilities | 2.97M | 378K | 112K | 5.56M | 1.03M | 313K | 61K | 40K | 39K | 342K |
Current Ratio | 9.22x | 10.46x | 5.56x | 6.68x | 5.95x | 4.27x | 4.02x | 2.94x | 1.23x | 3.74x |
Quick Ratio | 9.22x | 10.46x | 5.56x | 6.68x | 5.95x | 4.27x | 4.02x | 2.94x | 1.23x | 3.74x |
Cash Conversion Cycle | 8.34K | -1.83K | -4.34K | -67.39K | -31.05K | -27.85K | -12.38K | -10.76K | -22.32K | 1.1K |
Total Non-Current Liabilities | 5.86M | 161.85M | 169.29M | 182.29M | 183.71M | 99.79M | 81.64M | 67.44M | 7.04M | 122.64M |
Long-Term Debt | 4.7M | 160.05M | 165.05M | 168.91M | 173.3M | 66.07M | 64.67M | 57.45M | 1.64M | 117.8M |
Capital Lease Obligations | 307K | 1.47M | 1.38M | 10.17M | 8.05M | 5.98M | 5.53M | 4.81M | 3.92M | 16.68M |
Deferred Tax Liabilities | 0 | 321K | 1.77M | 1.19M | 767K | 602K | 510K | 455K | 145K | 600K |
Other Non-Current Liabilities | 849K | 937K | 1.08M | 2.02M | 1.6M | 1.32M | 1.23M | 978K | 1.34M | 1.36M |
Total Liabilities | 23.42M | 188.95M | 208.54M | 225.79M | 214.78M | 162.62M | 121.01M | 105.92M | 82.2M | 164.21M |
Total Debt | 6.25M | 163.75M | 169.59M | 183.62M | 185.69M | 74.23M | 75.28M | 70.18M | 62.13M | 138.91M |
Net Debt | -146.03M | -110.07M | -37.66M | -93.13M | 14.66M | -184.52M | -60.73M | -7.61M | -19.66M | 31.4M |
Debt / Equity | 0.04x | 1.57x | 8.10x | 2.18x | - | 0.62x | 0.80x | 1.03x | 0.90x | 2.65x |
Debt / EBITDA | - | - | - | - | - | 2.15x | - | - | 12.41x | 35.72x |
Net Debt / EBITDA | - | - | - | - | - | -5.34x | - | - | -3.93x | 8.07x |
Interest Coverage | -277.71x | -24.31x | -6.33x | -4.74x | -6.50x | 6.49x | -6.27x | -5.14x | 1.38x | -0.67x |
Total Equity | 142.8M▲ 0% | 104.23M▼ 27.0% | 20.94M▼ 79.9% | 84.06M▲ 301.5% | -16.16M▼ 119.2% | 119.1M▲ 836.9% | 94.53M▼ 20.6% | 67.95M▼ 28.1% | 69.22M▲ 1.9% | 52.47M▲ 0% |
Equity Growth % | 157.68% | -27.01% | -79.91% | 301.48% | -119.23% | 836.9% | -20.63% | -28.12% | 1.87% | -41.7% |
Book Value per Share | 5.32 | 3.34 | 0.67 | 2.27 | -0.42 | 2.14 | 1.90 | 1.37 | 1.38 | 1.05 |
Total Shareholders' Equity | 142.8M | 104.23M | 20.94M | 84.06M | -16.16M | 119.1M | 94.53M | 67.95M | 69.22M | 52.47M |
Common Stock | 7.79M | 7.79M | 7.8M | 9.71M | 9.72M | 12.45M | 12.46M | 12.46M | 12.5M | 12.5M |
Retained Earnings | -102.32M | -161.13M | -238.42M | -303.48M | -404.85M | -337.82M | -361.27M | -389.79M | -390.57M | -399.39M |
Treasury Stock | 0 | -127K | 0 | 0 | 0 | 0 | 0 | -970K | 0 | -1.1M |
Accumulated OCI | 21K | -8K | 6K | 14K | -92K | 22K | -1.34M | 996K | 347K | 185K |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GNFT Cash Flow Statement
Genfit S.A. (GNFT) cash flow — operating, investing & free cash flow history
| Metric | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Cash from Operations | -27.23M | -49.86M | -56.08M | -47.68M | -96.37M | 99.92M | -72.64M | -55.43M | 15.55M | -44.72M |
Operating CF Margin % | -9586.62% | -42250.85% | -81276.81% | -154.61% | -12597.52% | 124.79% | -359.68% | -194.05% | 23.21% | - |
Operating CF Growth % | -83.09% | -83.12% | -12.49% | 14.98% | -102.12% | 203.68% | -172.7% | 23.69% | 128.05% | 60.22% |
Net Income | -33.67M | -58.6M | -79.52M | -65.14M | -101.22M | 67.26M | -23.72M | -28.89M | 1.51M | -16.49M |
Depreciation & Amortization | 816K | 1.41M | 1.82M | 5.41M | 3.56M | 2.74M | 1.83M | 1.65M | 1.72M | 3.44M |
Stock-Based Compensation | 11K | 278K | 787K | 1.66M | 1.24M | 470K | 245K | 578K | 0 | 880K |
Deferred Taxes | 35K | 384K | -354K | -576K | -428K | 2.21M | -116K | 380K | 0 | 0 |
Other Non-Cash Items | -321K | 1.39M | 10.5M | 11.33M | 11.61M | -32.45M | 3.91M | -1.33M | 3.88M | 24.7M |
Working Capital Changes | 5.9M | 5.28M | 10.33M | -356K | -11.13M | 59.68M | -54.79M | -27.82M | 8.43M | -36.39M |
Change in Receivables | -2.94M | -2.11M | -724K | -1.64M | 318K | 4.34M | -8.56M | -17.42M | 23.96M | -26.43M |
Change in Inventory | 14K | 10K | 0 | 0 | 0 | 0 | 0 | 17.42M | 0 | 0 |
Change in Payables | 8.83M | 7.38M | 11.06M | 1.28M | -11.45M | 55.34M | -46.23M | -10.4M | -15.53M | -5.92M |
Cash from Investing | -2.09M | -2.95M | -3.99M | 327K | -966K | -3.38M | -46.27M | 2.23M | -1.04M | -4.71M |
Capital Expenditures | -2.04M | -2.8M | -2.94M | -2.03M | -900K | -537K | 0 | -2.49M | -979K | -2.45M |
CapEx % of Revenue | 716.9% | 2372.88% | 4257.97% | 6.58% | 117.65% | 0.67% | - | 8.71% | 1.46% | 2.09% |
Acquisitions | 0 | 15K | 3K | 2.52M | 0 | 309K | -41.52M | 0 | 0 | 2K |
Investments | - | - | - | - | - | - | - | - | - | - |
Other Investing | 1K | -148K | 2K | 2.52M | 0 | 308K | 271K | 172K | 80K | -1.94M |
Cash from Financing | 121.48M | 174.35M | -6.51M | 116.86M | -8.26M | -8.92M | -3.79M | -5.1M | -10.57M | 45.19M |
Debt Issued (Net) | 466K | 175.68M | -200K | -1.88M | -1.94M | -35.05M | -1.75M | -4.61M | -9.17M | 53.15M |
Equity Issued (Net) | 121.01M | 0 | 0 | 126.49M | 7K | 27.97M | 5K | 0 | 61K | -3.3M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing | 7K | -1.33M | -6.31M | -7.74M | -6.32M | -1.83M | -2.04M | -493K | -1.46M | -4.66M |
Net Change in Cash | 92.17M▲ 0% | 121.54M▲ 31.9% | -66.58M▼ 154.8% | 69.51M▲ 204.4% | -105.72M▼ 252.1% | 87.73M▲ 183.0% | -122.75M▼ 239.9% | -58.21M▲ 52.6% | 4M▲ 106.9% | -8.31M▲ 0% |
Free Cash Flow | -29.26M▲ 0% | -52.66M▼ 79.9% | -59.02M▼ 12.1% | -49.71M▲ 15.8% | -97.27M▼ 95.7% | 99.38M▲ 202.2% | -72.64M▼ 173.1% | -57.92M▲ 20.3% | 14.22M▲ 124.6% | -47.17M▲ 0% |
FCF Margin % | -10303.52% | -44623.73% | -85534.78% | -161.19% | -12715.16% | 124.12% | -359.68% | -202.76% | 21.22% | -40.38% |
FCF Growth % | -86.86% | -79.95% | -12.08% | 15.77% | -95.68% | 202.17% | -173.09% | 20.27% | 124.55% | -299.15% |
FCF per Share | -1.09 | -1.69 | -1.89 | -1.34 | -2.50 | 1.79 | -1.46 | -1.17 | 0.28 | -0.95 |
FCF Conversion (FCF/Net Income) | 0.81x | 0.85x | 0.71x | 0.73x | 0.95x | 1.49x | 3.06x | 1.92x | 10.32x | 2.86x |
Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 530K |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
GNFT Key Ratios
Genfit S.A. (GNFT) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
Return on Equity (ROE) | -33.97% | -47.45% | -127.06% | -124.08% | -298.13% | 130.68% | -22.21% | -35.57% | 2.2% | -22.98% |
Return on Invested Capital (ROIC) | - | - | - | - | - | - | -60.55% | -42.35% | 4.48% | 0.52% |
Gross Margin | -598.94% | -1788.98% | -2586.96% | 99.43% | 73.59% | 99.8% | 98.77% | 98.81% | 99.55% | 104.85% |
Net Margin | -11854.58% | -49664.41% | -115247.83% | -211.24% | -13231.5% | 84% | -117.45% | -101.15% | 2.25% | -14.12% |
Debt / Equity | 0.04x | 1.57x | 8.10x | 2.18x | - | 0.62x | 0.80x | 1.03x | 0.90x | 2.65x |
Interest Coverage | -277.71x | -24.31x | -6.33x | -4.74x | -6.50x | 6.49x | -6.27x | -5.14x | 1.38x | -0.67x |
FCF Conversion | 0.81x | 0.85x | 0.71x | 0.73x | 0.95x | 1.49x | 3.06x | 1.92x | 10.32x | 2.86x |
Revenue Growth | -46.11% | -58.45% | -41.53% | 44594.2% | -97.52% | 10366.54% | -74.78% | 41.45% | 134.56% | 9.75% |
Related:GNFT Dividend History·GNFT Revenue History·GNFT Price History·GNFT P/E History·GNFT Financial Ratios·GNFT Institutional Holders
GNFT Frequently Asked Questions
Genfit S.A. (GNFT) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Genfit S.A. (GNFT) reported $116.8M in revenue for fiscal year 2024. This represents a 841% increase from $12.4M in 2004.
Genfit S.A. (GNFT) grew revenue by 134.6% over the past year. This is strong growth.
Genfit S.A. (GNFT) reported a net loss of $16.5M for fiscal year 2024.
Dividend & Returns
Genfit S.A. (GNFT) has a return on equity (ROE) of 2.2%. This is below average, suggesting room for improvement.
Genfit S.A. (GNFT) had negative free cash flow of $47.2M in fiscal year 2024, likely due to heavy capital investments.